Loréal Olivier, Cavey Thibault, Bardou-Jacquet Edouard, Guggenbuhl Pascal, Ropert Martine, Brissot Pierre
INSERM UMR 991, Iron and the Liver Team Rennes, France ; Faculty of Medicine, University of Rennes1 Rennes, France ; CHU Pontchaillou, French Reference Centre for Rare Iron Overload Diseases of Genetic Origin, University Hospital-Rennes Rennes, France.
INSERM UMR 991, Iron and the Liver Team Rennes, France ; Faculty of Medicine, University of Rennes1 Rennes, France ; Biochemistry and Enzymology Laboratory, Centre Hospitalier Universitaire Rennes, France.
Front Pharmacol. 2014 Jun 4;5:128. doi: 10.3389/fphar.2014.00128. eCollection 2014.
Identification of new players in iron metabolism, such as hepcidin, which regulates ferroportin and divalent metal transporter 1 expression, has improved our knowledge of iron metabolism and iron-related diseases. However, from both experimental data and clinical findings, "iron-related proteins" appear to also be involved in the metabolism of other metals, especially divalent cations. Reports have demonstrated that some metals may affect, directly or indirectly, the expression of proteins involved in iron metabolism. Throughout their lives, individuals are exposed to various metals during personal and/or occupational activities. Therefore, better knowledge of the connections between iron and other metals could improve our understanding of iron-related diseases, especially the variability in phenotypic expression, as well as a variety of diseases in which iron metabolism is secondarily affected. Controlling the metabolism of other metals could represent a promising innovative therapeutic approach.
铁代谢新相关蛋白的发现,如调节铁转运蛋白和二价金属转运体1表达的铁调素,增进了我们对铁代谢及铁相关疾病的了解。然而,从实验数据和临床研究结果来看,“铁相关蛋白”似乎也参与了其他金属的代谢,尤其是二价阳离子的代谢。有报告表明,某些金属可能直接或间接影响参与铁代谢的蛋白质的表达。在个人生活和/或职业活动中,人们一生都会接触到各种金属。因此,深入了解铁与其他金属之间的联系,有助于我们更好地理解铁相关疾病,尤其是表型表达的变异性,以及各种铁代谢继发受影响的疾病。控制其他金属的代谢可能是一种有前景的创新治疗方法。